United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - primidone - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

serb - primidone - oral tablet - 250mg

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - primidone, quantity: 250 mg - tablet, uncoated - excipient ingredients: carmellose calcium; povidone; gelatin; magnesium stearate; stearic acid - management of grand mal and psychomotor (temporal lobe) epilepsy. it is also of value in the management of focal or jacksonian seizures, myoclonic jerks and akinetic attacks.

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratoires serb - primidone - tablet - 250 milligram(s) - barbiturates and derivatives; primidone

Ireland - English - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - primidone - tablet - 250 milligram(s) - barbiturates and derivatives; primidone

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - primidone - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - primidone - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - primidone - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - primidone - oral tablet - 250mg

United States - English - NLM (National Library of Medicine)

bausch health us, llc - primidone (unii: 13afd7670q) (primidone - unii:13afd7670q) - primidone 50 mg - mysoline, used alone or concomitantly with other anticonvulsants, is indicated in the control of grand mal, psychomotor, and focal epileptic seizures. it may control grand mal seizures refractory to other anticonvulsant therapy. primidone is contraindicated in: 1) patients with porphyria and 2) patients who are hypersensitive to phenobarbital (see actions ).